Results 61 to 70 of about 17,867 (215)

Onchocerciasis Control

open access: yes, 2019
The recognition of onchocerciasis as a major public health problem in the savanna belts of West Africa resulted in the establishment of the Onchocerciasis Control Programme (OCP) in 1974.
Davies, J.B., Molyneux, D.H.
core   +1 more source

An appraisal of the neglected tropical diseases control program in Cameroon: the case of the national program against onchocerciasis

open access: yesBMC Public Health, 2017
Background Onchocerciasis is a severe parasitic infestation which causes disabling skin and subcutaneous tissue changes. Current global estimates suggest that it accounts for 1135.7 disability adjusted life years (DALYs) per 100,000 population.
Tsi Njim, Leopold Ndemnge Aminde
doaj   +1 more source

Natural Products as Geroprotective Modulators in Diabetic Nephropathy: A Mechanistic Framework Integrating Aging Hallmarks and the AMPK–SIRT1–Nrf2 Axis

open access: yesAging and Cancer, Volume 7, Issue 2, Page 52-66, June 2026.
Natural products target the aging kidney in diabetic nephropathy by restoring the AMPK–SIRT1–Nrf2 axis, reducing oxidative stress, inflammation, fibrosis, and cellular senescence while enhancing mitochondrial biogenesis and antioxidant defenses.
Sherif Hamidu   +8 more
wiley   +1 more source

Low prevalence of epilepsy and onchocerciasis after more than 20 years of ivermectin treatment in the Imo River Basin in Nigeria

open access: yesInfectious Diseases of Poverty, 2019
Background High epilepsy prevalence and incidence have been reported in areas with high onchocerciasis transmission. Recent findings suggest that proper community-directed treatment with ivermectin (CDTI) is potentially able to prevent onchocerciasis ...
Joseph N. F. Siewe   +18 more
doaj   +1 more source

Disease perception, impacts and coping strategies for onchocerciasis in Southeast Nigeria: a qualitative study among patients and program managers

open access: yesBMC Public Health, 2023
Background Onchocerciasis is a disease of public health concern due to the devastating consequences of the disease which impacts negatively on the lives of the people.
Adah E. Otache   +5 more
doaj   +1 more source

Beyond birds: rethinking bird‐centered pathogen models in light of insect migration

open access: yesEcography, Volume 2026, Issue 6, June 2026.
Migration redistributes biomass, nutrients, and pathogens across ecosystems. For decades, migratory birds have been treated as the default long‐distance pathogen vectors, shaping both conceptual frameworks and empirical models of disease ecology.
Virginia Morandini
wiley   +1 more source

In Silico Design and Computational Characterization of Novel Chimeric Multiepitope Antigens for Mpox Serosurveillance: An Immunoinformatics Approach

open access: yesHealth Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background and Aims The Monkeypox (Mpox) virus is a zoonotic Orthopoxvirus with a global outbreak that began in 2022, with more than 132,000 confirmed cases and 1500 deaths across over 128 countries. The pandemic preparedness pipeline emphasizes the importance of diagnostic surveillance of pathogens in at‐risk populations to monitor ...
Roland Ngwese Akwelle   +20 more
wiley   +1 more source

Case definitions for onchocerciasis-associated epilepsy and nodding syndrome : a focused review

open access: yes, 2023
: Onchocerciasis-associated epilepsy (OAE) is an important but neglected public health problem in onchocerciasis-endemic areas with insufficient or inadequate onchocerciasis control.
Njamnshi, A.K.   +5 more
core   +1 more source

ANALISIS KESTABILAN DAN KONTROL OPTIMAL MODEL MATEMATIKA PENYEBARAN PENYAKIT ONCHOCERCIASIS [PDF]

open access: yes, 2019
Onchocerciasis merupakan salah satu penyakit yang menyerang mata dan kulit pada manusia sehingga menyebabkan kebutaan dan infeksi pada kulit.
NURUL IFDAYATI, 081511233038
core   +1 more source

Ivermectin Toxicity in Humans and Animals: Clinical Spectrum, Mechanisms, and Management

open access: yesJournal of Applied Toxicology, Volume 46, Issue 6, Page 1856-1870, June 2026.
ABSTRACT Ivermectin is a widely used macrocyclic lactone with established efficacy against a broad range of parasitic infections in humans and animals and a long‐standing reputation for clinical safety. However, increasing evidence indicates that ivermectin can produce clinically relevant toxicity under specific conditions, particularly involving the ...
Serkan Yilmaz   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy